Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CRRVX | 9.08 | -0.41 | -4.32% |
| Columbia Real Estate Equity Inst2 | |||
| AIEMX | 9.91 | -0.52 | -4.99% |
| Alger Emerging Markets I | |||
| JEMCX | 27.05 | -1.53 | -5.35% |
| JPMorgan Emerging Markets Equity C | |||
| GCVCX | 20.62 | -1.34 | -6.10% |
| Goldman Sachs Large Cp Val Insghts C | |||
| FBTTX | 21.22 | -1.43 | -6.31% |
| Fidelity Advisor Biotechnology M | |||
A.I.dvisor indicates that over the last year, SER has been closely correlated with LIANY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if SER jumps, then LIANY could also see price increases.
| Ticker / NAME | Correlation To SER | 1D Price Change % | ||
|---|---|---|---|---|
| SER | 100% | -4.37% | ||
| LIANY - SER | 69% Closely correlated | +0.10% | ||
| GERN - SER | 65% Loosely correlated | -6.12% | ||
| XTLB - SER | 59% Loosely correlated | +3.25% | ||
| ELVN - SER | 37% Loosely correlated | -6.69% | ||
| TOVX - SER | 34% Loosely correlated | -8.47% | ||
More | ||||